UK markets closed

Hypertension Diagnostics, Inc. (HDII)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00020.0000 (0.00%)
At close: 10:58AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 56.96k
Enterprise value 56.96k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.14
Price/book (mrq)N/A
Enterprise value/revenue 0.02
Enterprise value/EBITDA 0.79

Trading information

Stock price history

Beta (5Y monthly) -2.53
52-week change 3-92.86%
S&P500 52-week change 322.36%
52-week high 30.0040
52-week low 30.0001
50-day moving average 30.0007
200-day moving average 30.0010

Share statistics

Avg vol (3-month) 31.57k
Avg vol (10-day) 3N/A
Shares outstanding 5284.78M
Implied shares outstanding 61.42B
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.00%
Shares short (10 Apr 2003) 4N/A
Short ratio (10 Apr 2003) 40.01
Short % of float (10 Apr 2003) 4N/A
Short % of shares outstanding (10 Apr 2003) 40.00%
Shares short (prior month 11 Feb 2003) 412.05k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2018
Most-recent quarter (mrq)31 Mar 2013

Profitability

Profit margin -3.31%
Operating margin (ttm)-45,304.02%

Management effectiveness

Return on assets (ttm)0.03%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)3.79M
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA 36.71k
Net income avi to common (ttm)-125.39k
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.66k
Total cash per share (mrq)0
Total debt (mrq)1.3M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.52
Book value per share (mrq)-0.09

Cash flow statement

Operating cash flow (ttm)-389.28k
Levered free cash flow (ttm)-432k